Vir Biotechnology VIR
NASDAQ VIR
$10.65 +0.14 (+1.33%)
At close: Sep 29, 2026 · 4:00 PM EDT

Vir Biotechnology (VIR) Operating Expenses (2018 - 2026)

Updated

Vir Biotechnology's Operating Expenses was $165.48 million in Q2 2026, up 38.3% from $119.63 million a year earlier and up 25.1% from the prior quarter.

Analysis

Vir Biotechnology (VIR) Operating Expenses (2018 - 2026) Analysis & Trends

On a trailing twelve-month basis, Vir Biotechnology's Operating Expenses was $583.41 million through Jun 30, 2026, down 6.7% year-over-year; for FY2025, it came in at $547.88 million, down 17.2% from FY2024.

  • Operating Expenses has now declined for three consecutive years, though with a five-year compound annual growth rate of 8.0% (FY2020 to FY2025).
  • In earlier years, Operating Expenses was $661.37 million in FY2024 (-14.2%), $770.49 million in FY2023 (-1.6%), $782.73 million in FY2022 (+16.0%) and $674.66 million in FY2021 (+80.7%).
  • Quarterly Operating Expenses has moved between $111.99 million (Q4 2025) and $241 million (Q4 2021) over five years.
  • Compared with a year earlier, Operating Expenses was higher in three of the last eight quarters, with an average decline of 2.9%.
  • The best year-over-year quarter for Operating Expenses over five years was Q4 2021 (growth of 118.8%); the worst was Q1 2024 (a decline of 33.9%).
  • Per Business Quant data, VIR's Operating Expenses in the three quarters before Q2 2026 was $132.26 million (Q1 2026), $111.99 million (Q4 2025) and $173.68 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Opex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 10.12 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 10.56 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 12.80 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -6.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -9.70 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 6.54 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 18.20 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 6.68 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 2.09 Bn
10 Vir Biotechnology 1.78 Bn 1.78 Bn 238.95 Mn 165.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 165.48 Mn
Mar 31, 2026 132.26 Mn
Dec 31, 2025 111.99 Mn
Sep 30, 2025 173.68 Mn
Jun 30, 2025 119.63 Mn
Mar 31, 2025 142.58 Mn
Dec 31, 2024 129.52 Mn
Sep 30, 2024 233.68 Mn
Jun 30, 2024 161.71 Mn
Mar 31, 2024 136.46 Mn
Dec 31, 2023 155.80 Mn
Sep 30, 2023 189.37 Mn
Jun 30, 2023 218.98 Mn
Mar 31, 2023 206.33 Mn
Dec 31, 2022 199.91 Mn
Sep 30, 2022 179.59 Mn
Jun 30, 2022 184.59 Mn
Mar 31, 2022 218.63 Mn
Dec 31, 2021 241.00 Mn
Sep 30, 2021 157.00 Mn
API Access

Vir Biotechnology Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-expenses&ticker=VIR&period=max&api_key=YOUR_API_KEY